Robert Verkerk
Overview
Explore the profile of Robert Verkerk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
1031
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Almulla A, Vasupanrajit A, Tunvirachaisakul C, Al-Hakeim H, Solmi M, Verkerk R, et al.
Mol Psychiatry
. 2022 Apr;
27(9):3679-3691.
PMID: 35422466
The tryptophan catabolite (TRYCAT) pathway is implicated in the pathophysiology of schizophrenia (SCZ) since the rate-limiting enzyme indoleamine-dioxygenase (IDO) may be induced by inflammatory and oxidative stress mediators. This systematic...
2.
Coppens V, Verkerk R, Morrens M
Front Pharmacol
. 2022 Mar;
13:825948.
PMID: 35250576
No abstract available.
3.
Skorobogatov K, De Picker L, Verkerk R, Coppens V, Leboyer M, Muller N, et al.
Front Immunol
. 2021 Oct;
12:716980.
PMID: 34630391
Objective: Disturbances in the kynurenine pathway have been implicated in the pathophysiology of psychotic and mood disorders, as well as several other psychiatric illnesses. It remains uncertain however to what...
4.
Vliegen G, Kehoe K, Bracke A, De Hert E, Verkerk R, Fransen E, et al.
PLoS One
. 2020 Apr;
15(4):e0231555.
PMID: 32315321
The proline-specific enzymes dipeptidyl peptidase 4 (DPP4), prolylcarboxypeptidase (PRCP), fibroblast activation protein α (FAP) and prolyl oligopeptidase (PREP) are known for their involvement in the immune system and blood pressure...
5.
De Picker L, Fransen E, Coppens V, Timmers M, de Boer P, Oberacher H, et al.
Front Immunol
. 2020 Feb;
10:2971.
PMID: 32010121
Different patterns of immune system upregulation are present in the acute vs. post-treatment states of psychotic illness. We explored the existence of state and trait markers in the peripheral immune...
6.
van den Ameele S, van Nuijs A, Lai F, Schuermans J, Verkerk R, van Diermen L, et al.
Bipolar Disord
. 2019 Aug;
22(1):59-69.
PMID: 31398273
Objectives: Cytokines are thought to contribute to the pathogenesis of psychiatric symptoms by kynurenine pathway activation. Kynurenine metabolites affect neurotransmission and can cause neurotoxicity. We measured inflammatory markers in patients...
7.
Ormstad H, Bryn V, Verkerk R, Skjeldal O, Halvorsen B, Saugstad O, et al.
CNS Neurol Disord Drug Targets
. 2018 Jul;
17(8):626-639.
PMID: 30033880
Background: There is evidence that changes in neuro-immune responses coupled with dysfunctions in serotonin metabolism underpin the pathophysiology of autism spectrum disorders (ASD). Objective: This study aimed to delineate whether...
8.
Bryn V, Verkerk R, Skjeldal O, Saugstad O, Ormstad H
Neuropsychobiology
. 2018 Apr;
76(2):82-88.
PMID: 29694960
Background: There is increasing evidence that altered immune responses play a role in the pathogenesis of autism spectrum disorders (ASD), together with dysfunction of the serotonergic and glutamatergic systems. Since...
9.
Baerts L, Brouns R, Kehoe K, Verkerk R, Engelborghs S, De Deyn P, et al.
Transl Stroke Res
. 2016 Aug;
8(2):157-164.
PMID: 27561653
Dipeptidyl peptidase IV (DPPIV) inhibition may be a promising therapeutic strategy for acute stroke treatment, given its potential to prolong the biological half-life of neuroprotective substrates. A related protease, fibroblast...
10.
Kehoe K, Van Elzen R, Verkerk R, Sim Y, Van der Veken P, Lambeir A, et al.
Biochim Biophys Acta
. 2016 Jul;
1864(11):1481-8.
PMID: 27449720
No abstract available.